Results 151 to 160 of about 6,034 (173)

Maraviroc Reduces the Regulatory T-Cell Frequency in Antiretroviral-Naive HIV-Infected Subjects

Journal of Infectious Diseases, 2014
Ezequiel Ruiz-Mateos, Mª Angeles Muñoz-Fernández, Yolanda M Pacheco   +2 more
exaly  

Maraviroc pharmacokinetics investigated

Inpharma Weekly, 2008
openaire   +2 more sources

Dexamethasone/maraviroc

Reactions Weekly, 2015
openaire   +1 more source

Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients

Journal of Antimicrobial Chemotherapy, 2010
Eduardo Seclen, Carmen de Mendoza, Antonio Aguilera   +2 more
exaly  

New drugs: Maraviroc and lanreotide

Journal of the American Pharmacists Association, 2007
openaire   +2 more sources

Maraviroc

2009
openaire   +1 more source

Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc

Bioorganic and Medicinal Chemistry Letters, 2006
David Price, Manos Perros, Anthony Wood   +2 more
exaly  

Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects

British Journal of Clinical Pharmacology, 2008
exaly  

An expedient synthesis of maraviroc (UK-427,857) via C–H functionalization

Tetrahedron Letters, 2015
Justin Du Bois, T Aaron Bedell, Erik Sorensen   +2 more
exaly  

Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

British Journal of Clinical Pharmacology, 2008
exaly